Grupo Concesionario del Oeste S.A. (BCBA:OEST)

Akoya Biosciences Ratios and Metrics

Market cap in millions ARS. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 13, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	114,400	183,200	119,200	16,480	6,536	4,640
Market Cap Growth	-38.12%	53.69%	623.30%	152.14%	40.86%	-0.69%
Enterprise Value	93,405	173,596	116,542	13,709	5,671	4,124
Last Close Price	715.00	1145.00	745.00	103.00	40.85	29.00
PE Ratio	5.22	-	1.97	4.04	-	-
PS Ratio	1.50	2.71	1.87	0.47	0.44	0.56
PB Ratio	0.87	1.78	0.82	0.42	0.58	0.75
P/FCF Ratio	7.41	46.72	-	2.93	19.44	-
P/OCF Ratio	6.73	31.02	-	2.63	14.13	-
EV/Sales Ratio	1.23	2.57	1.83	0.39	0.38	0.50
EV/EBITDA Ratio	-	-	-	59.68	1.08	-
EV/EBIT Ratio	-	-	-	-	1.14	-
EV/FCF Ratio	6.05	44.27	-	2.44	16.86	-
Debt / Equity Ratio	-	-	-	-	-	0.04
Asset Turnover	0.39	0.31	0.39	0.70	0.80	0.60
Inventory Turnover	274.87	337.83	484.07	374.29	292.00	179.73
Quick Ratio	1.50	1.20	0.82	1.48	0.82	0.77
Current Ratio	1.91	1.60	1.40	1.99	1.56	1.29
Return on Equity (ROE)	20.42%	-34.20%	65.64%	16.23%	-10.32%	-71.95%
Return on Assets (ROA)	-1.94%	-3.66%	-5.19%	-0.50%	16.77%	-28.52%
Return on Capital (ROIC)	-3.50%	-6.49%	-9.22%	-1.00%	35.24%	-54.33%
Return on Capital Employed (ROCE)	-	-	-	-	24.60%	-
Earnings Yield	19.14%	-23.24%	50.89%	24.77%	-13.79%	-109.45%
FCF Yield	13.50%	2.14%	-2.63%	34.17%	5.15%	-3.27%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.